Details
Clearbridge Health Limited commenced trading today. Its IPO price was at $0.28, which unfortunately was not open to public subscription, and it ended its first day of trading flat at the same price.
Business
Clearbridge specialises in precision medicine, which is the practice of identifying the individual characteristics of each patient as well as probability of diseases, based on their genomic and metabolomics profile.
They also offer Clinical diagnostic tests through their in-house laboratory, SAM Laboratory Pte Ltd, which includes:
- Health screening
- Cancer diagnosis
- Biomarker diagnostics, capable of surveying for over 138 possible conditions
- Treatment monitoring and prognosis
......
